PDS Biotechnology
PDSB
PDSB
46 hedge funds and large institutions have $109M invested in PDS Biotechnology in 2016 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
31% less capital invested
Capital invested by funds: $158M → $109M (-$48.9M)
Holders
46
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.07M | |
| 2 | +$1.69M | |
| 3 | +$903K | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$633K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$560K |
Top Sellers
| 1 | -$16.2M | |
| 2 | -$231K | |
| 3 | -$201K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$109K |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$64.8K |